Charles River Analytics Inc., developer of intelligent systems solutions, has received additional funding from the US National Institutes of Health (NIH) to build our Constructed Environments for Successfully Sustaining Abstinence Through Immersive and On-Demand Treatment (CESSATION) virtual reality (VR) system. CESSATION uses behavioral therapies in VR to better combat nicotine dependency and mitigate relapse. We have partnered with MedStar Health for the two-year CESSATION follow-on contract, which is valued at $1 million.
“Current methods for smoking cessation are effective, but the odds of relapse remain high,” said Dr. Bethany Bracken, Senior Scientist at Charles River Analytics and Principal Investigator on the CESSATION effort. “Our CESSATION app helps reduce nicotine dependency through VR. CESSATION maximized efficacy of existing behavioral therapies, making them more immersive and accessible, both to widen the audience and to encourage more frequent and consistent use.”
Screenshot from the Phase I CESSATION virtual reality system showing a choice between a smoking cue (the smoking cigarette in the ash tray on the right) and a neutral cue (the glass of water on the left) to allow smokers to practice resisting smoking cues
We intend for CESSATION to become a commercially available, affordable app that gives smokers unparalleled access to cessation therapy. Once smokers download the app, they can access tools at their convenience—outside of scheduled doctor visits and especially during nicotine cravings.
The CESSATION effort furthers our growing portfolio of efforts in mixed reality/virtual reality/augmented reality and healthcare support and training. CESSATION uses our Sherlock™ platform, with which we can create realistic apps that reason about human physiological, neurological, and behavioral states.
Contact us to learn more about CESSATION or our other virtual and augmented reality projects.
This project has been funded in whole or in part with Federal funds from the National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN271201700037C.
To learn more about Charles River or our current projects and capabilities, contact us.
Charles River Analytics conducts leading-edge AI, robotics, and human-machine interface R&D and leverages that R&D to create custom solutions for your organization.
At Charles River Analytics, we come to work every day because we want to develop technology for the hardest human-machine teaming problems that impact critical operations and decision-making. In 1983, we began focusing on research that leads to results, initially working for the US government. We became an employee-owned company in 2012, setting the stage for the next generation of innovation, service, and growth. Today, we have nearly 200 employees who work on R&D and commercial programs that make a difference for a “who’s who” of government and industry.
We have a stellar track record developing successful solutions for Government and commercial clients across a diverse collection of markets—defense, intelligence, medical technology, training, transportation, space, and cyber security. Our success is based on our expertise with advanced algorithms, machine learning, autonomous systems, advanced human-system interfaces, and agile software and hardware engineering. Focused research can make a positive difference, and that is our goal on each project we undertake. Our customer-centric focus guides us towards problems that matter, while our passion for science and engineering drives us to find impactful, actionable solutions.